SRPL NSE filing

Shree Ram Proteins Limited Concludes 16th AGM with Overwhelming Support for Resolutions

The RealCase readMedium impact Positive

Shree Ram Proteins Limited held its 16th AGM on March 05, 2026, via VC/OAVM. Shareholders overwhelmingly approved resolutions including the adoption of FY24 financial statements, re-appointment of a director, and appointment of two new independent directors. Remuneration for the cost auditor was also ratified.

Why it matters

The appointment of new directors and ratification of financial statements are material events for the company.

The market read

All resolutions were passed with a high percentage of votes in favor, indicating strong shareholder support.

Shree Ram Proteins Limited held its 16th Annual General Meeting (AGM) on Thursday, March 05, 2026, commencing at 11:00 a.m. IST, through Video Conferencing (VC) and Other Audio Visual Means (OAVM).

The meeting was convened to consider and adopt the audited financial statements for the financial year ended March 31, 2024, along with the reports of the Board of Directors and Auditors. Shareholders also voted on the re-appointment of a director retiring by rotation and the regularization/appointment of two additional directors, Mr. Akash Suresh bhai Gajera and Mr. Yogesh Chandubhai Dhanani, as Independent Directors.

Furthermore, the remuneration payable to M/s. Tadhani & Co., Cost Accountants, for the financial year ended March 31, 2025, was ratified. All resolutions presented at the AGM received substantial support from the shareholders, as indicated by the voting results inclusive of remote e-voting and e-voting during the AGM. The company submitted the Consolidated Voting Results and the Consolidated Scrutinizers’ Report to the National Stock Exchange of India Limited on March 06, 2026.

Filing to action

What to do with a filing like this

Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.

View original filing